Europe Preventive Vaccine market by Vaccine Type (Live, Attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines), by End User (Paediatric and Adult Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Preventive Vaccine market by Vaccine Type (Live, Attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines), by End User (Paediatric and Adult Vaccines) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 142 | Pages: 135 | December 2016 | Region: Europe


The Europe Preventive Vaccine market is estimated at $7.86 Billion in 2015 and is poised to reach $ 14.03 billion by 2020 with a compound annual growth rate of 12.28 %. Recently there has been a substantial growth in the vaccine market with the rising incidences of cancer & HIV cases. World Health Organization growth estimations indicate the market may increase in value to almost 54.5 billion 2020, with the arrival of new therapeutic preventive, and adult vaccines.

The vaccine Market is quite different from any other product market, having distinct features with increased complexity of assessing, understanding prices and procurement. Although it is a small market compared to the pharmaceutical market, we cannot dismiss the fact that it is growing at a fast rate. There are currently around 120 new vaccines in the pipeline of various multinational companies across the world and are set to hit the market in the coming years. While the vaccine market is rather concentrated on both supply and demand sides, it is mostly dependent on public purchasers and donor policies.

Introduction of new vaccines for every other diseases is aiding the growth of vaccine market. Also, rise in the frequency of occurrence of infectious diseases like tuberculosis, hepatitis, diphtheria and pneumococcal diseases across the globe has increased the usage of vaccines. Invested from governments for vaccine development, increase in funding by the major market players, rising occurrence of disease, technological advancements decreasing the new vaccine development time drastically, initiatives by NGO’s are some of the factors that are propelling the growth of vaccines However, there are few factors restraining the growth of vaccine market like, huge capital expenditures and stringent regulatory policies by the governments, massive cost associated with treatment.

The Europe Preventive Vaccines Market is segmented by type of vaccine as Live, attenuated vaccines, inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines. In addition, based on age groups the market is categorized as Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and others) and Adult vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and others). Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France.

Historically many of the multinational vaccine companies have been investing huge sums in research and development resulting in new innovations in the market. The major players in the preventive vaccine market are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                           

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                              

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                            

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                     

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                               

  1. Market Segmentation

                5.1 By Vaccine Type                                                       

                                5.1.1 Live, Attenuated Vaccines                                

                                5.1.2 Inactivted Vaccines                                             

                                5.1.3 Toxoid Vaccines                                    

                                5.1.4 Subunit vaccines                                  

                                5.1.5 Conjugate vaccines                                             

                                5.1.6 DNA vaccines                                         

                                5.1.7 Recombinant vector vaccines                                          

                5.2 By End User                                               

                                5.2.1 Paediatric Vaccine                                

                                                5.2.1.1 Pneumococcal                   

                                                5.2.1.2 MMR                     

                                                5.2.1.3 Varicella               

                                                5.2.1.4 Hepatitis                              

                                                5.2.1.5 Poliovirus                             

                                                5.2.1.6 HIB                         

                                                5.2.1.7 Others                  

                                5.2.2 Adult Vaccines                                      

                                                5.2.2.1 Influenza                             

                                                5.2.2.2 Cervical Cancer                 

                                                5.2.2.3 Hepatitis                              

                                                5.2.2.4 Zoster                   

                                                5.2.2.5 Others                  

  1. Geographical Analysis

                6.1 Introduction                                                              

                6.2 U.K                                                

                6.3 Spain                                                             

                6.4 Germany                                                     

                6.5 Italy                                                               

                6.6 France                                                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                      

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                               

                                7.2.5 Competitive Rivalry within the Industry                                      

  1. Market Leaders' Analysis

                8.1 GlaxoSmithKline, plc.                                                             

                                8.1.1 Overview                                

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                            

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Merck and Company                                                              

                8.3 Bavarian Nordic                                                        

                8.4 CSL Limited                                                 

                8.5 Emergent BioSolutions Inc.                                                  

                8.6 Novartis AG                                                

                8.7 Johnson and Johnson                                                             

                8.8 MedImmune, LLC                                                    

                8.9 Pfizer, Inc.                                                   

                8.10 Sanofi Pasteur                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                          

                9.4 New Product Launches                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  2. Europe Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  3. Europe Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  4. Europe Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  5. Europe Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  6. Europe Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  7. Europe Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  8. Europe DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  9. Europe Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  10. Europe Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  11. Europe Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  12. Europe Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  13. Europe Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  14. Europe Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  15. Europe MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  16. Europe Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  17. Europe Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  18. Europe Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  19. Europe HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  20. Europe Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  21. Europe Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  22. Europe Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  23. Europe Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  24. Europe Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  25. Europe Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  26. Europe Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  27. U.K. Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  28. U.K. Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  29. Germany Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  30. Germany Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  31. France Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  32. France Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  33. Italy Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  34. Italy Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  35. Spain Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  36. Spain Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  37. U.K. Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  38. Germany Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  39. France Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  40. Italy Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  41. Spain Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  42. U.K. Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  43. Germany Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  44. France Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  45. Italy Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  46. Spain Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.